Skip to main content
TipRanks
Go Ultimate75% OFF

Ilan Katz Insider Profile

4 Followers

Ilan Katz, Director, Ten Percent Owner at SAB Biotherapeutics, holds 3.05M shares in SAB Biotherapeutics (Ticker: SABS). Most recently, Ilan Katz Bought 500 shares of SAB Biotherapeutics on Oct 15, 2021 for an estimated value of $5.05K.

Ilan Katz's Trading History

SABS
SAB Biotherapeutics
Oct 15, 2021Director, Ten Percent OwnerInformative Buy5.05K$9.03M
SABS
Insider Shares: 3.05M (20.61%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 15, 2021Informative Buy$5.05K500$10.10-92.10%
Oct 05, 2021Informative Buy$10.09K1,000$10.09-91.50%

You May Also Like

Ilan Katz insider profile FAQ

What is the percentage of profitable transactions made by Ilan Katz?
The percentage of profitable transactions made by Ilan Katz is 0%.
What is the average return per transaction made by Ilan Katz?
The average return per transaction made by Ilan Katz is -91.80%.
What stocks does Ilan Katz hold?
Ilan Katz holds: SABS stocks.
What was Ilan Katz’s latest transaction?
Ilan Katz’s latest transaction was an Informative Buy of $5.05K.
What was Ilan Katz's most profitable transaction?
Ilan Katz’s most profitable transaction was an Informative Buy of SABS stock on October 5, 2021. The return on the trade was -91.50%.
What is Ilan Katz's role in SAB Biotherapeutics?
Ilan Katz's role in SAB Biotherapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.